Patents by Inventor Cynthia Ann Richards

Cynthia Ann Richards has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020042137
    Abstract: The present invention provides a system for simple generation of recombinant animal viruses. The system includes a virus homing vector and can further comprise a transfer vector. These components are used in a system that reduces the number of cloning steps and provides for easier preparation of a number of recombinant viruses.
    Type: Application
    Filed: July 11, 2001
    Publication date: April 11, 2002
    Inventors: Cynthia Ann Richards, Michael Phillip Weiner
  • Patent number: 6291214
    Abstract: The present invention provides a system for simple generation of recombinant animal viruses. The system includes a virus homing vector and can further comprise a transfer vector. These components are used in a system that reduces the number of cloning steps and provides for easier preparation of a number of recombinant viruses.
    Type: Grant
    Filed: May 10, 1999
    Date of Patent: September 18, 2001
    Assignee: Glaxo Wellcome Inc.
    Inventors: Cynthia Ann Richards, Michael Phillip Weiner
  • Patent number: 6194211
    Abstract: The transcriptional regulatory sequence (TRS) of Carcinoembryonic Antigen (CEA) and molecular chimeras comprising the CEA TRS and DNA encoding a heterologous enzyme are described. Such molecular chimeras are capable of targeting the expression of the heterologous enzyme to CEA-positive cells. The heterologous enzyme may be cytosine deaminase.
    Type: Grant
    Filed: May 16, 1996
    Date of Patent: February 27, 2001
    Assignee: Glaxo Wellcome Inc.
    Inventors: Cynthia Ann Richards, Brian Huber